Top

European Journal of Medical Research

Published in:

Open Access 01-12-2023 | Septicemia | Research

Early administration of multiple vasopressors is associated with better survival in patients with sepsis: a propensity score-weighted study

Authors: Xin Tong, Xiaopeng Xue, Chuanzhi Duan, Aihua Liu

Published in: European Journal of Medical Research | Issue 1/2023

Abstract

Background

The association between the timing of administration of multiple vasopressors and patient outcomes has not been investigated.

Methods

This study used data from the MIMIC-IV database. Patients with sepsis who were administered two or more vasopressors were included. The principal exposure was the last norepinephrine dose when adding a second vasopressor. The cohort was divided into early (last norepinephrine dose < 0.25 μg/kg/min) and normal (last norepinephrine dose ≥ 0.25 μg/kg/min) groups. The primary outcome was 28-day mortality. Multivariable Cox analyses, propensity score matching, stabilized inverse probability of treatment weighting (sIPTW), and restricted cubic spline (RCS) curves were used.

Results

Overall, 1,437 patients who received multiple vasopressors were included. Patients in the early group had lower 28-day mortality (HR: 0.76; 95% CI: 0.65–0.89; p < 0.001) than those in the single group, with similar results in the propensity score-matched (HR: 0.80; 95% CI: 0.68–0.94; p = 0.006) and sIPTW (HR: 0.75; 95% CI: 0.63–0.88; p < 0.001) cohorts. RCS curves showed that the risk of 28-day mortality increased as the last norepinephrine dose increased.

Conclusions

The timing of secondary vasopressor administration is strongly associated with the outcomes of patients with sepsis.

Available only for authorised users

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49:e1063–143.CrossRefPubMed

De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–89.CrossRefPubMed

Vincent J-L, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726–34.CrossRefPubMed

Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki L-M, Pettilä V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005;31:1066–71.CrossRefPubMed

Wieruszewski PM, Khanna AK. Vasopressor choice and timing in vasodilatory shock. Crit Care. 2022;26:76.CrossRefPubMedPubMedCentral

Beck V, Chateau D, Bryson GL, Pisipati A, Zanotti S, Parrillo JE, et al. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care Lond Engl. 2014;18:R97.CrossRef

Li Y, Li H, Zhang D. Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis. Crit Care. 2020;24:488.CrossRefPubMedPubMedCentral

Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of refractory vasodilatory shock. Chest. 2018;154:416–26.CrossRefPubMed

Guerci P, Belveyre T, Mongardon N, Novy E. When to start vasopressin in septic shock: the strategy we propose. Crit Care. 2022;26:125.CrossRefPubMedPubMedCentral

10.

Shi R, Hamzaoui O, De Vita N, Monnet X, Teboul J-L. Vasopressors in septic shock: which, when, and how much? Ann Transl Med. 2020;8:794.CrossRefPubMedPubMedCentral

11.

Ospina-Tascón GA, Hernandez G, Bakker J. Should we start vasopressors very early in septic shock? J Thorac Dis. 2020;12:3893–6.CrossRefPubMedPubMedCentral

12.

Chawla LS, Ostermann M, Forni L, Tidmarsh GF. Broad spectrum vasopressors: a new approach to the initial management of septic shock? Crit Care Lond Engl. 2019;23:124.CrossRef

13.

Scheeren TWL, Bakker J, De Backer D, Annane D, Asfar P, Boerma EC, et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019;9:20.CrossRefPubMedPubMedCentral

14.

Johnson AE, Pollard TJ, Shen L, Lehman LW, Feng M, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035.CrossRefPubMedPubMedCentral

15.

Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, et al. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000;101:E215-220.CrossRefPubMed

16.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–10.CrossRefPubMedPubMedCentral

17.

Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419–30.CrossRefPubMed

18.

Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care. 2020;55:145–8.CrossRefPubMed

19.

Dünser MW, Takala J, Ulmer H, Mayr VD, Luckner G, Jochberger S, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009;35:1225–33.CrossRefPubMed

20.

Maheshwari K, Nathanson BH, Munson SH, Khangulov V, Stevens M, Badani H, et al. The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients. Intensive Care Med. 2018;44:857–67.CrossRefPubMedPubMedCentral

21.

Xu F, Zhong R, Shi S, Zeng Y, Tang Z. Early initiation of norepinephrine in patients with septic shock: a propensity score-based analysis. Am J Emerg Med. 2022;54:287–96.CrossRefPubMed

22.

Toro C, Ohnuma T, Komisarow J, Vavilala MS, Laskowitz DT, James ML, et al. Early vasopressor utilization strategies and outcomes in critically ill patients with severe traumatic brain injury. Anesth Analg. 2022. https://doi.org/10.1213/ANE.0000000000005949.CrossRefPubMed

23.

Hamzaoui O, Shi R. Early norepinephrine use in septic shock. J Thorac Dis. 2020;12:S72–7.CrossRefPubMedPubMedCentral

24.

Black LP, Puskarich MA, Smotherman C, Miller T, Fernandez R, Guirgis FW. Time to vasopressor initiation and organ failure progression in early septic shock. J Am Coll Emerg Physicians Open. 2020;1:222–30.CrossRefPubMedPubMedCentral

25.

Russell JA, Gordon AC, Williams MD, Boyd JH, Walley KR, Kissoon N. Vasopressor therapy in the intensive care unit. Semin Respir Crit Care Med. 2021;42:59–77.CrossRefPubMed

26.

Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med. 2019;199:1097–105.CrossRefPubMed

27.

Juste RN, Panikkar K, Soni N. The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med. 1998;24:564–8.CrossRefPubMed

28.

Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96:576–82.CrossRefPubMed

29.

Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, et al. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med. 2019;45:844–55.CrossRefPubMed

30.

Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock. Crit Care Med. 2022;50:614–23.CrossRefPubMed

31.

Nakada T-A, Russell JA, Boyd JH, Aguirre-Hernandez R, Thain KR, Thair SA, et al. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Respir Crit Care Med. 2010;181:143–9.CrossRefPubMed

32.

Nakada T, Russell JA, Boyd JH, McLaughlin L, Nakada E, Thair SA, et al. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med. 2011;39:1641–8.CrossRefPubMed

33.

Nakada T-A, Russell JA, Wellman H, Boyd JH, Nakada E, Thain KR, et al. Leucyl/cystinyl aminopeptidase gene variants in septic shock. Chest. 2011;139:1042–9.CrossRefPubMed

34.

Bucher M, Kees F, Taeger K, Kurtz A. Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med. 2003;31:566–71.CrossRefPubMed

35.

Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, et al. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care Lond Engl. 2014;18:534.CrossRef

Title: Early administration of multiple vasopressors is associated with better survival in patients with sepsis: a propensity score-weighted study
Authors: Xin Tong
Xiaopeng Xue
Chuanzhi Duan
Aihua Liu
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Septicemia
Septicemia
Published in: European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI: https://doi.org/10.1186/s40001-023-01229-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Early administration of multiple vasopressors is associated with better survival in patients with sepsis: a propensity score-weighted study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Remimazolam tosylate's long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety

Predictors of bacteremia and death, including immune status, in a large single-center cohort of unvaccinated ICU patients with COVID-19 pneumonia

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Clinical values of serum Semaphorin 4D (Sema4D) in medication‑related osteonecrosis of the jaw

High return to sports rates after operative treatment of patella fractures

The effect of nanomaterials on embryonic stem cell neural differentiation: a systematic review